Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →INOVIO Pharmaceuticals
Grant: SRA 21-04
National Institutes of Health
Grant: 1P50CA261608-01
SPORE in Skin Cancer
NCI NIH HHS
Grant: P30 CA010815
NCI NIH HHS
Grant: P50 CA261608
NCI NIH HHS
Grant: R50 CA211199
NCI NIH HHS
Grant: T32 CA009171
NIAID NIH HHS
Grant: U19 AI166916
FWCI
1.08
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals